Table II.
Transfusion history in the year prior to entry into the EPIC study for patients included in these analyses.
| All regions | Europe | Middle East/Africa | Asia-Pacific | |
|---|---|---|---|---|
| Mean ± SD number of transfusion sessions in the year prior to study entry, n | ||||
| TM | 17.5±8.8 (n=935) | 22.7±10.6 (n=279) | 15.8±8.3 (n=240) | 14.9±5.5 (n=416) |
| TI | 13.5±7.1 (n=82) | 12.5±11.6 (n=19) | 10.9±4.5 (n=7) | 14.2±5.2 (n=56) |
| MDS | 24.3±17.7 (n=335) | 25.7±18.3 (n=288) | 12.0±0.0 (n=2) | 16.0±10.2 (n=45) |
| AA | 12.5±13.0 (n=114) | 18.0±20.7 (n=28) | 12.0±7.4 (n=5) | 10.7±8.8 (n=81) |
| Mean ± SD volume blood transfused in the year prior to study entry, mL/kg | ||||
| TM | 189.8±139.3 (n=917) | 190.9±210.3 (n=263) | 141.4±76.9 (n=240) | 217.2±97.2 (n=414) |
| TI | 155.4±87.0 (n=80) | 63.2±73.5 (n=17) | 97.2±56.6 (n=7) | 190.7±68.1 (n=56) |
| MDS | 116.4±123.1 (n=302) | 117.5±128.2 (n=255) | 83.8±25.3 (n=2) | 111.3±93.2 (n=45) |
| AA | 115.8±179.4 (n=112) | 129.6±138.1 (n=26) | 113.6±35.7 (n=5) | 111.4±196.4 (n=81) |
Legend: numbers in brackets are the total numbers of patients with the specific diagnosis within the geographical region. Data for SCD patients are not given in this table as some patients received exchange transfusions.